R&D Day Luncheon hosted by Theravance Biopharma

Theravance Biopharma management and R&D teams will provide an overview of its R&D strategy, plus clinical programs and emerging research projects in the therapeutic areas of inflammatory intestinal diseases, autonomic disorders, severe asthma, lung transplant rejection, idiopathic pulmonary fibrosis, and diabetic macular edema.